Gonorrhea Therapeutics Market 2027 By Infection type, Treatment, Route of administration, Distribution channel and Geography | The Insight Partners

Gonorrhea Therapeutics Market to 2027 - Global Analysis and Forecasts By Infection type (Uncomplicated Gonococcal Infection, Gonococcal Arthritis, Gonococcal Meningitis and Endocarditis) ; Treatment (Monotherapy, Dual therapy) ; Route of administration (Oral, Injectable) ; Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) , and Geography

Report Code: TIPRE00006831 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Gonorrhea is a sexually transmitted disease (STD). It is caused by bacterium Neisseria gonorrhoeae. It tends to infect warm, moist areas of the body like urethra, eyes, throat, vagina, anus, and female reproductive tract. Gonorrhea transfers from person to person through unprotected sex. Newborns can be infected during delivery if their mothers are infected. In infants, disease most commonly affects the eyes. Symptoms usually happen within two to 14 days after exposure. However, some people affected by gonorrhea never develop prominent symptoms. People are more likely to spread the infection to other partners when they don't have notable symptoms

MARKET DYNAMICS

Gonorrhea therapeutics market is anticipated to grow in the forecast period owing to driving factors such as the Increasing prevalence of gonorrhea, coupled with the rising public awareness about STDs (Sexually-Transmitted Diseases). Moreover, advances in relevant diagnostic methods, rising investments by prominent players for the growing demand are also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Gonorrhea therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gonorrhea therapeutics market with detailed market segmentation by infection type, treatment, by route of administration, by distribution channel and geography. The global gonorrhea therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading gonorrhea therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global gonorrhea therapeutics market is segmented on the basis of infection type, treatment, by route of administration, by distribution channel. Based on infection type, the market is segmented as Uncomplicated Gonococcal Infection, Gonococcal Arthritis and Gonococcal Meningitis and Endocarditis. Based on treatment, the market is segmented as monotherapy and dual therapy. Based on route of administration, the market is segmented as Oral and Injectable. Based on distribution channel the market is segmented as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Gonorrhea therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gonorrhea therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting gonorrhea therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gonorrhea therapeutics market in these regions.

MARKET PLAYERS


The report covers key developments in the gonorrhea therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from gonorrhea therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for gonorrhea therapeutics in the global market. Below mentioned is the list of few companies engaged in the gonorrhea therapeutics market.

The report also includes the profiles of key gonorrhea therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GlaxoSmithKline plc.
  •  Merck & Co., Inc.
  •  Pfizer Inc.
  •  AstraZeneca
  •  Hologic, Inc.
  •  Allergan plc
  •  Sanofi S.A.
  •  F. Hoffmann-La Roche Ltd
  •  Becton Dickinson and Company
  •  Abbott
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gonorrhea Therapeutics Market - By Infection type
1.3.2 Gonorrhea Therapeutics Market - By Treatment
1.3.3 Gonorrhea Therapeutics Market - By Route of administration
1.3.4 Gonorrhea Therapeutics Market - By Distribution channel
1.3.5 Gonorrhea Therapeutics Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GONORRHEA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS

5. GONORRHEA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GONORRHEA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. GONORRHEA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. GONORRHEA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. GONORRHEA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - INFECTION TYPE
7.1. OVERVIEW
7.2. INFECTION TYPE MARKET FORECASTS AND ANALYSIS
7.3. UNCOMPLICATED GONOCOCCAL INFECTION
7.3.1. Overview
7.3.2. Uncomplicated Gonococcal Infection Market Forecast and Analysis
7.4. GONOCOCCAL ARTHRITIS
7.4.1. Overview
7.4.2. Gonococcal Arthritis Market Forecast and Analysis
7.5. GONOCOCCAL MENINGITIS AND ENDOCARDITIS
7.5.1. Overview
7.5.2. Gonococcal Meningitis and Endocarditis Market Forecast and Analysis

8. GONORRHEA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
8.1. OVERVIEW
8.2. TREATMENT MARKET FORECASTS AND ANALYSIS
8.3. MONOTHERAPY
8.3.1. Overview
8.3.2. Monotherapy Market Forecast and Analysis
8.4. DUAL THERAPY
8.4.1. Overview
8.4.2. Dual therapy Market Forecast and Analysis

9. GONORRHEA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INJECTABLE
9.4.1. Overview
9.4.2. Injectable Market Forecast and Analysis

10. GONORRHEA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis

11. GONORRHEA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Gonorrhea Therapeutics Market Overview
11.1.2 North America Gonorrhea Therapeutics Market Forecasts and Analysis
11.1.3 North America Gonorrhea Therapeutics Market Forecasts and Analysis - By Infection type
11.1.4 North America Gonorrhea Therapeutics Market Forecasts and Analysis - By Treatment
11.1.5 North America Gonorrhea Therapeutics Market Forecasts and Analysis - By Route of administration
11.1.6 North America Gonorrhea Therapeutics Market Forecasts and Analysis - By Distribution channel
11.1.7 North America Gonorrhea Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Gonorrhea Therapeutics Market
11.1.7.1.1 United States Gonorrhea Therapeutics Market by Infection type
11.1.7.1.2 United States Gonorrhea Therapeutics Market by Treatment
11.1.7.1.3 United States Gonorrhea Therapeutics Market by Route of administration
11.1.7.1.4 United States Gonorrhea Therapeutics Market by Distribution channel
11.1.7.2 Canada Gonorrhea Therapeutics Market
11.1.7.2.1 Canada Gonorrhea Therapeutics Market by Infection type
11.1.7.2.2 Canada Gonorrhea Therapeutics Market by Treatment
11.1.7.2.3 Canada Gonorrhea Therapeutics Market by Route of administration
11.1.7.2.4 Canada Gonorrhea Therapeutics Market by Distribution channel
11.1.7.3 Mexico Gonorrhea Therapeutics Market
11.1.7.3.1 Mexico Gonorrhea Therapeutics Market by Infection type
11.1.7.3.2 Mexico Gonorrhea Therapeutics Market by Treatment
11.1.7.3.3 Mexico Gonorrhea Therapeutics Market by Route of administration
11.1.7.3.4 Mexico Gonorrhea Therapeutics Market by Distribution channel
11.2. EUROPE
11.2.1 Europe Gonorrhea Therapeutics Market Overview
11.2.2 Europe Gonorrhea Therapeutics Market Forecasts and Analysis
11.2.3 Europe Gonorrhea Therapeutics Market Forecasts and Analysis - By Infection type
11.2.4 Europe Gonorrhea Therapeutics Market Forecasts and Analysis - By Treatment
11.2.5 Europe Gonorrhea Therapeutics Market Forecasts and Analysis - By Route of administration
11.2.6 Europe Gonorrhea Therapeutics Market Forecasts and Analysis - By Distribution channel
11.2.7 Europe Gonorrhea Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Gonorrhea Therapeutics Market
11.2.7.1.1 Germany Gonorrhea Therapeutics Market by Infection type
11.2.7.1.2 Germany Gonorrhea Therapeutics Market by Treatment
11.2.7.1.3 Germany Gonorrhea Therapeutics Market by Route of administration
11.2.7.1.4 Germany Gonorrhea Therapeutics Market by Distribution channel
11.2.7.2 France Gonorrhea Therapeutics Market
11.2.7.2.1 France Gonorrhea Therapeutics Market by Infection type
11.2.7.2.2 France Gonorrhea Therapeutics Market by Treatment
11.2.7.2.3 France Gonorrhea Therapeutics Market by Route of administration
11.2.7.2.4 France Gonorrhea Therapeutics Market by Distribution channel
11.2.7.3 Italy Gonorrhea Therapeutics Market
11.2.7.3.1 Italy Gonorrhea Therapeutics Market by Infection type
11.2.7.3.2 Italy Gonorrhea Therapeutics Market by Treatment
11.2.7.3.3 Italy Gonorrhea Therapeutics Market by Route of administration
11.2.7.3.4 Italy Gonorrhea Therapeutics Market by Distribution channel
11.2.7.4 Spain Gonorrhea Therapeutics Market
11.2.7.4.1 Spain Gonorrhea Therapeutics Market by Infection type
11.2.7.4.2 Spain Gonorrhea Therapeutics Market by Treatment
11.2.7.4.3 Spain Gonorrhea Therapeutics Market by Route of administration
11.2.7.4.4 Spain Gonorrhea Therapeutics Market by Distribution channel
11.2.7.5 United Kingdom Gonorrhea Therapeutics Market
11.2.7.5.1 United Kingdom Gonorrhea Therapeutics Market by Infection type
11.2.7.5.2 United Kingdom Gonorrhea Therapeutics Market by Treatment
11.2.7.5.3 United Kingdom Gonorrhea Therapeutics Market by Route of administration
11.2.7.5.4 United Kingdom Gonorrhea Therapeutics Market by Distribution channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Gonorrhea Therapeutics Market Overview
11.3.2 Asia-Pacific Gonorrhea Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Gonorrhea Therapeutics Market Forecasts and Analysis - By Infection type
11.3.4 Asia-Pacific Gonorrhea Therapeutics Market Forecasts and Analysis - By Treatment
11.3.5 Asia-Pacific Gonorrhea Therapeutics Market Forecasts and Analysis - By Route of administration
11.3.6 Asia-Pacific Gonorrhea Therapeutics Market Forecasts and Analysis - By Distribution channel
11.3.7 Asia-Pacific Gonorrhea Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Gonorrhea Therapeutics Market
11.3.7.1.1 Australia Gonorrhea Therapeutics Market by Infection type
11.3.7.1.2 Australia Gonorrhea Therapeutics Market by Treatment
11.3.7.1.3 Australia Gonorrhea Therapeutics Market by Route of administration
11.3.7.1.4 Australia Gonorrhea Therapeutics Market by Distribution channel
11.3.7.2 China Gonorrhea Therapeutics Market
11.3.7.2.1 China Gonorrhea Therapeutics Market by Infection type
11.3.7.2.2 China Gonorrhea Therapeutics Market by Treatment
11.3.7.2.3 China Gonorrhea Therapeutics Market by Route of administration
11.3.7.2.4 China Gonorrhea Therapeutics Market by Distribution channel
11.3.7.3 India Gonorrhea Therapeutics Market
11.3.7.3.1 India Gonorrhea Therapeutics Market by Infection type
11.3.7.3.2 India Gonorrhea Therapeutics Market by Treatment
11.3.7.3.3 India Gonorrhea Therapeutics Market by Route of administration
11.3.7.3.4 India Gonorrhea Therapeutics Market by Distribution channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Gonorrhea Therapeutics Market Overview
11.4.2 Middle East and Africa Gonorrhea Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Gonorrhea Therapeutics Market Forecasts and Analysis - By Infection type
11.4.4 Middle East and Africa Gonorrhea Therapeutics Market Forecasts and Analysis - By Treatment
11.4.5 Middle East and Africa Gonorrhea Therapeutics Market Forecasts and Analysis - By Route of administration
11.4.6 Middle East and Africa Gonorrhea Therapeutics Market Forecasts and Analysis - By Distribution channel
11.4.7 Middle East and Africa Gonorrhea Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Gonorrhea Therapeutics Market
11.4.7.1.1 South Africa Gonorrhea Therapeutics Market by Infection type
11.4.7.1.2 South Africa Gonorrhea Therapeutics Market by Treatment
11.4.7.1.3 South Africa Gonorrhea Therapeutics Market by Route of administration
11.4.7.1.4 South Africa Gonorrhea Therapeutics Market by Distribution channel
11.4.7.2 Saudi Arabia Gonorrhea Therapeutics Market
11.4.7.2.1 Saudi Arabia Gonorrhea Therapeutics Market by Infection type
11.4.7.2.2 Saudi Arabia Gonorrhea Therapeutics Market by Treatment
11.4.7.2.3 Saudi Arabia Gonorrhea Therapeutics Market by Route of administration
11.4.7.2.4 Saudi Arabia Gonorrhea Therapeutics Market by Distribution channel
11.4.7.3 U.A.E Gonorrhea Therapeutics Market
11.4.7.3.1 U.A.E Gonorrhea Therapeutics Market by Infection type
11.4.7.3.2 U.A.E Gonorrhea Therapeutics Market by Treatment
11.4.7.3.3 U.A.E Gonorrhea Therapeutics Market by Route of administration
11.4.7.3.4 U.A.E Gonorrhea Therapeutics Market by Distribution channel

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. GONORRHEA THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. GLAXOSMITHKLINE PLC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERCK AND CO., INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ASTRAZENECA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. HOLOGIC, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ALLERGAN PLC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SANOFI S.A.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. F. HOFFMANN-LA ROCHE LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BECTON DICKINSON AND COMPANY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ABBOTT
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc.
2. Merck & Co., Inc.
3. Pfizer Inc.
4. AstraZeneca
5. Hologic, Inc.
6. Allergan plc
7. Sanofi S.A.
8. F. Hoffmann-La Roche Ltd
9. Becton Dickinson and Company
10. Abbott